Literature DB >> 10879569

Control of antibiotic use in the community: the Danish experience.

T L Sørensen1, D Monnet.   

Abstract

The selection pressure for antibacterial resistance in the community might not be as high as in hospitals. However, it is generally accepted that it is in the primary healthcare sector that one can achieve the greatest decrease in the total use of antimicrobials. There are significant differences in the overall use of antimicrobials among European countries. On average, 80% to 90% of the total antibiotic use in each country takes place in the primary healthcare sector. Surveillance of the use of antimicrobials is the core for planning interventions and monitoring their effect. These interventions may be implemented for either political, economic, or professional reasons. Often, but not always, political interventions are governmental, and professional interventions are recommendations from professional associations. Examples of interventions at different levels in the Danish healthcare system, from the general practitioner to legislation by the government, will be presented together with their effect on the use of antimicrobials.

Mesh:

Substances:

Year:  2000        PMID: 10879569     DOI: 10.1086/501778

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  3 in total

Review 1.  Effects of computer-aided clinical decision support systems in improving antibiotic prescribing by primary care providers: a systematic review.

Authors:  Jakob Holstiege; Tim Mathes; Dawid Pieper
Journal:  J Am Med Inform Assoc       Date:  2014-08-14       Impact factor: 4.497

2.  Geographic variation in outpatient antibiotic prescribing among older adults.

Authors:  Yuting Zhang; Michael A Steinman; Cameron M Kaplan
Journal:  Arch Intern Med       Date:  2012-10-22

3.  Impact of national interventions to promote responsible antibiotic use: a systematic review.

Authors:  Jane Mingjie Lim; Shweta Rajkumar Singh; Minh Cam Duong; Helena Legido-Quigley; Li Yang Hsu; Clarence C Tam
Journal:  J Antimicrob Chemother       Date:  2020-01-01       Impact factor: 5.790

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.